5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 44.82▼ | 44.88▼ | 44.91▼ | 44.53▲ | 42.87▲ |
MA10 | 44.87▼ | 44.95▼ | 44.89▼ | 44.22▲ | 42.09▲ |
MA20 | 44.89▼ | 44.89▼ | 44.73▲ | 42.85▲ | 41.66▲ |
MA50 | 44.95▼ | 44.60▲ | 44.35▲ | 41.91▲ | 37.55▲ |
MA100 | 44.90▼ | 44.32▲ | 43.43▲ | 41.75▲ | 41.86▲ |
MA200 | 44.77▼ | 43.31▲ | 42.22▲ | 38.61▲ | 47.49▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.012▼ | -0.038▼ | -0.023▼ | 0.212▲ | 0.171▲ |
RSI | 33.707▼ | 47.158▼ | 53.030▲ | 64.193▲ | 59.697▲ |
STOCH | 15.383▼ | 30.544 | 49.033 | 86.626▲ | 70.602 |
WILL %R | -90.196▼ | -94.737▼ | -79.058▼ | -16.325▲ | -10.623▲ |
CCI | -166.022▼ | -175.176▼ | -84.074 | 89.837 | 169.877▲ |
Thursday, May 16, 2024 04:00 AM
MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa VELA is the first Phase 3 program in hidradenitis ...
|
Thursday, May 16, 2024 03:29 AM
Development of BIIB105, an investigational antisense oligonucleotide for amyotrophic lateral sclerosis (ALS), will be discontinued based on data from the Phase 1/2 ALSpire studyBiogen and Ionis ...
|
Wednesday, May 15, 2024 01:46 PM
Hopes that inflation is finally heading back in the right direction swept through Wall Street today, igniting a record-setting rally for stocks.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/05/24 | 45.19 | 45.19 | 44.71 | 44.74 | 1,193,314 |
15/05/24 | 44.95 | 45.5399 | 44.525 | 45.10 | 1,624,248 |
14/05/24 | 44.50 | 44.57 | 44.03 | 44.55 | 1,335,809 |
13/05/24 | 44.60 | 44.63 | 43.90 | 43.94 | 1,177,156 |
10/05/24 | 44.49 | 44.49 | 43.82 | 44.32 | 936,350 |
09/05/24 | 44.06 | 44.485 | 43.85 | 44.29 | 1,210,316 |
08/05/24 | 43.18 | 44.19 | 43.02 | 44.13 | 1,112,225 |
07/05/24 | 43.98 | 44.27 | 43.69 | 43.81 | 1,448,632 |
06/05/24 | 44.15 | 44.18 | 43.604 | 43.70 | 1,431,749 |
03/05/24 | 43.56 | 44.10 | 43.235 | 43.62 | 1,956,970 |
|
|
||||
|
|
||||
|
|